ABN AMRO
Progress on ABN AMRO share buyback programme 7 August - 14 August 2025
Progress on ABN AMRO share buyback programme 7 August - 14 August 2025
Progress on ABN AMRO share buyback programme 7 August - 14 August 2025
ABN AMRO reports the transaction details related to its EUR 250 million share buyback programme announced on 6 August 2025.
During the week of 7 August 2025 up to and including 14 August 2025 a total of 2,400,000 shares and depositary receipts were repurchased at an average price of €25.72 for a total amount of € 61,717,760.
For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions and weekly reports, see the ABN AMRO website at https://www.abnamro.com/en/investor-relations/information/share-buyback-programme.
To date the total consideration for shares and depositary receipts repurchased amounts to € 61,717,760 representing 24.69% of the overall share buyback programme.
This press release is published by ABN AMRO Bank N.V. and contains inside information within the meaning of article 7 (1) to (4) of Regulation (EU) No 596/2014 (Market Abuse Regulation).
Note to editors, not for publication.
For more information, please contact
ABN AMRO Press Office: e-mail: pressrelations@nl.abnamro.com, phone number: +31 (0)20 6288900
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Digitalist Group Oyj16.8.2025 10:05:48 CEST | Press release
REGISTRATION OF THE COMBINATION OF SHARES OF DIGITALIST GROUP PLC, AND ADJUSTMENT OF THE MAXIMUM NUMBERS OF SHARES AVAILABLE FOR SUBSCRIPTION UNDER THE COMPANY’S CONVERTIBLE LOANS AND 2021 STOCK OPTION PROGRAM, AND THE SUBSCRIPTION PRICES
Leading Edge Materials Corp.15.8.2025 23:30:00 CEST | Press release
LEADING EDGE MATERIALS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT
Novo Nordisk A/S15.8.2025 23:23:24 CEST | Press release
Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH
Vaisala Group15.8.2025 17:30:00 CEST | Press release
Vaisala Corporation: Share Repurchase 15.8.2025
Ress Life Investments A/S15.8.2025 17:15:00 CEST | Press release
Ress Life Investments A/S publishes Net Asset Value (NAV).
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom